Published in Mol Pharm on April 02, 2014
Application and assessment of optical clearing methods for imaging of tissue-engineered neural stem cell spheres. Tissue Eng Part C Methods (2014) 0.88
High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures. Assay Drug Dev Technol (2015) 0.85
Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response. Pancreas (2016) 0.79
Liquid-based three-dimensional tumor models for cancer research and drug discovery. Exp Biol Med (Maywood) (2016) 0.78
Delivery of Human Adipose Stem Cells Spheroids into Lockyballs. PLoS One (2016) 0.75
On-chip clearing of arrays of 3-D cell cultures and micro-tissues. Biomicrofluidics (2016) 0.75
Architecture of Chimeric Spheroids Controls Drug Transport. Cancer Microenviron (2015) 0.75
Targeting multidrug resistance in cancer. Nat Rev Drug Discov (2006) 10.55
Drug penetration in solid tumours. Nat Rev Cancer (2006) 9.80
Membrane transporters in drug development. Nat Rev Drug Discov (2010) 8.56
Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol (1999) 6.62
Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature (1983) 5.80
Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A (1987) 5.65
Mammalian ABC transporters in health and disease. Annu Rev Biochem (2001) 4.90
Diffusion and scaling during early embryonic pattern formation. Proc Natl Acad Sci U S A (2005) 3.46
Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther (2001) 2.67
Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov (2007) 2.19
Drug delivery and transport to solid tumors. Pharm Res (2003) 2.05
Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology (2001) 2.05
Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun (1986) 1.95
The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today (2008) 1.93
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo. J Clin Invest (2002) 1.90
Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci (2004) 1.87
Physiological transport forces govern drug distribution for stent-based delivery. Circulation (2001) 1.83
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol (1997) 1.73
Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng (2007) 1.69
A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci (2010) 1.67
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res (1996) 1.57
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos (2006) 1.50
The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res (2009) 1.46
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res (2003) 1.34
Clinical trials of P-glycoprotein reversal in solid tumours. Eur J Cancer (1996) 1.33
Quantification of the forces driving self-assembly of three-dimensional microtissues. Proc Natl Acad Sci U S A (2011) 1.20
Advantages and limitations of commonly used methods to assay the molecular permeability of gap junctional intercellular communication. Biotechniques (2008) 1.20
Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells. Am J Physiol Heart Circ Physiol (2012) 1.07
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study. J Clin Oncol (2001) 1.07
Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines. Cancer Res (1990) 1.06
Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein. Eur J Pharm Sci (2006) 1.05
Connexon-mediated cell adhesion drives microtissue self-assembly. FASEB J (2010) 1.01
P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells. Biochem Pharmacol (1999) 1.00
Rapid detection of ABC transporter interaction: potential utility in pharmacology. J Pharmacol Toxicol Methods (2010) 0.99
Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids. Cancer Chemother Pharmacol (1984) 0.95
A mathematical model of tumor oxygen and glucose mass transport and metabolism with complex reaction kinetics. Radiat Res (2003) 0.94
Gap junctional intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis (1999) 0.91
Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. Cancer Res (1984) 0.89
Quantification of the kinetics and extent of self-sorting in three dimensional spheroids. Tissue Eng Part C Methods (2011) 0.89
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancer. J Clin Oncol (1996) 0.86
Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. Drug Discov Today (2007) 0.86
Origin of carcinoma in secretory endometrium--a study using a whole-organ sectioning technique. Gynecol Oncol (1983) 0.83
Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds. J Biomol Screen (2010) 0.77
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 4.35
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Dynamics of the self-assembly of complex cellular aggregates on micromolded nonadhesive hydrogels. Tissue Eng (2007) 1.69
Au-Fe3O4 dumbbell nanoparticles as dual-functional probes. Angew Chem Int Ed Engl (2008) 1.64
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys J (2004) 1.61
Rods, tori, and honeycombs: the directed self-assembly of microtissues with prescribed microscale geometries. FASEB J (2007) 1.57
Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels. Biotechniques (2007) 1.46
Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem (2008) 1.45
Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys Chem (2002) 1.38
Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther (2012) 1.25
Quantification of the forces driving self-assembly of three-dimensional microtissues. Proc Natl Acad Sci U S A (2011) 1.20
Cytoskeletal-mediated tension modulates the directed self-assembly of microtissues. Tissue Eng Part A (2008) 1.09
Self-assembly and tissue fusion of toroid-shaped minimal building units. Tissue Eng Part A (2010) 1.09
Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg (2002) 1.07
Controlling cell position in complex heterotypic 3D microtissues by tissue fusion. Biotechnol Bioeng (2009) 1.06
Connexon-mediated cell adhesion drives microtissue self-assembly. FASEB J (2010) 1.01
Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol (2006) 0.99
Viscoelastic response of human skin to low magnitude physiologically relevant shear. J Biomech (2008) 0.97
Necking and failure of constrained 3D microtissues induced by cellular tension. Proc Natl Acad Sci U S A (2013) 0.96
Measurements of kinetic parameters in a microfluidic reactor. Anal Chem (2006) 0.93
Fibroblast elongation and dendritic extensions in constrained versus unconstrained microtissues. Cell Motil Cytoskeleton (2009) 0.93
Biocompatible nanoparticles trigger rapid bacteria clustering. Biotechnol Prog (2009) 0.91
Microfluidic reactors for diagnostics applications. Annu Rev Biomed Eng (2011) 0.91
FGF-7 expression enhances the performance of bioengineered skin. Mol Ther (2004) 0.90
Encapsulated arrays of self-assembled microtissues: an alternative to spherical microcapsules. Tissue Eng Part A (2009) 0.89
Directed self-assembly of large scaffold-free multi-cellular honeycomb structures. Biofabrication (2011) 0.89
Quantification of the kinetics and extent of self-sorting in three dimensional spheroids. Tissue Eng Part C Methods (2011) 0.89
A TGF-beta1-dependent autocrine loop regulates the structure of focal adhesions in hypertrophic scar fibroblasts. J Invest Dermatol (2006) 0.89
Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles. Theranostics (2012) 0.88
Pannexin1 drives multicellular aggregate compaction via a signaling cascade that remodels the actin cytoskeleton. J Biol Chem (2012) 0.88
Real-time droplet DNA amplification with a new tablet platform. Anal Chem (2012) 0.87
Localization of magnetic pills. Proc Natl Acad Sci U S A (2011) 0.84
Mechanotransduction is enhanced by the synergistic action of heterotypic cell interactions and TGF-β1. FASEB J (2012) 0.83
Identification of an ICP27-responsive element in the coding region of a herpes simplex virus type 1 late gene. J Virol (2009) 0.82
A simple method for amplifying RNA targets (SMART). J Mol Diagn (2012) 0.82
Miniaturization of an Anoikis assay using non-adhesive micromolded hydrogels. Cytotechnology (2007) 0.82
Surface-tension-induced synthesis of complex particles using confined polymeric fluids. Angew Chem Int Ed Engl (2010) 0.81
Micro-mold design controls the 3D morphological evolution of self-assembling multicellular microtissues. Tissue Eng Part A (2013) 0.81
Horizons in prosthesis development for the restoration of limb function. J Am Acad Orthop Surg (2006) 0.81
Nanoneedle method for high-sensitivity low-background monitoring of protein activity. Langmuir (2008) 0.81
Understanding gastric forces calculated from high-resolution pill tracking. Proc Natl Acad Sci U S A (2010) 0.81
Sequestration and synthesis: the source of insulin in cell clusters differentiated from murine embryonic stem cells. Stem Cells (2005) 0.80
Kinetic measurements of protein conformation in a microchip. Biotechnol Prog (2006) 0.80
Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets. J Clin Microbiol (2013) 0.80
Intrinsic viscosity of polymers and biopolymers measured by microchip. Anal Chem (2005) 0.80
Direct sequence detection of structured h5 influenza viral RNA. J Mol Diagn (2008) 0.80
Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts. Cell Transplant (2004) 0.80
Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells. Oncotarget (2013) 0.80
Controlled release of vanadium from titanium oxide coatings for improved integration of soft tissue implants. J Biomed Mater Res A (2009) 0.79
Platelet-derived growth factor-AA-mediated functional angiogenesis in the rat epigastric island flap after genetic modification of fibroblasts is ischemia dependent. Surgery (2002) 0.79
Steric effects and mass-transfer limitations surrounding amplification reactions on immobilized long and clinically relevant DNA templates. Langmuir (2009) 0.79
Are in vivo gastric bioadhesive forces accurately reflected by in vitro experiments? J Control Release (2008) 0.79
Electrophoretic migration of proteins in semidilute polymer solutions. Electrophoresis (2008) 0.79
Optimization of microfluidic fuel cells using transport principles. Anal Chem (2007) 0.79
New insights into the transformation of calcium sulfate hemihydrate to gypsum using time-resolved cryogenic transmission electron microscopy. Langmuir (2012) 0.79
Biohybrid limbs: new materials and new properties. Med Health R I (2007) 0.79
Rapid screening, in vitro study of metal oxide and polymer hybrids as delivery coatings for improved soft-tissue integration of implants. J Biomed Mater Res A (2010) 0.78
Measurements of label free protein concentration and conformational changes using a microfluidic UV-LED method. Biotechnol Prog (2007) 0.78
In vitro characterization of TGF-beta1 release from genetically modified fibroblasts in Ca(2+)-alginate microcapsules. ASAIO J (2005) 0.78
Improved antimicrobial potency through synergistic action of chitosan microparticles and low electric field. Appl Biochem Biotechnol (2012) 0.78
In vitro maturation of oocytes via the pre-fabricated self-assembled artificial human ovary. J Assist Reprod Genet (2010) 0.78
Detection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART). J Mol Diagn (2013) 0.78
Human keratinocytes cultured on collagen matrix used as an experimental burn model. J Burns Wounds (2007) 0.77
Metal oxide coated cell culture arrays for rapid biological screening. J Biomed Mater Res A (2007) 0.77
Massive electrical conductivity enhancement of multilayer graphene/polystyrene composites using a nonconductive filler. ACS Appl Mater Interfaces (2014) 0.77
Capture and separation of biomolecules using magnetic beads in a simple microfluidic channel without an external flow device. Analyst (2013) 0.77
Microdroplet sandwich real-time rt-PCR for detection of pandemic and seasonal influenza subtypes. PLoS One (2013) 0.77
Transient hyperproliferation of a transgenic human epidermis expressing hepatocyte growth factor. Cell Transplant (2002) 0.77
Evaluation of continuous flow nanosphere formation by controlled microfluidic transport. Langmuir (2008) 0.77
Homogeneous percolation versus arrested phase separation in attractively-driven nanoemulsion colloidal gels. Soft Matter (2014) 0.77
Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model. Transplantation (2002) 0.76
Bioinspired bioadhesive polymers: dopa-modified poly(acrylic acid) derivatives. Macromol Biosci (2012) 0.76
Three-dimensional confinement-related size changes to mixed-surfactant vesicles. Langmuir (2008) 0.76
Early in vitro transcription termination in human H5 influenza viral RNA synthesis. Appl Biochem Biotechnol (2011) 0.76
A platform for retaining native morphology at sub-second time scales in cryogenic transmission electron microscopy. Rev Sci Instrum (2013) 0.76
A localizable, biological-based system for the delivery of bioactive IGF-1 utilizing microencapsulated genetically modified human fibroblasts. ASAIO J (2009) 0.76
Phase and steady shear behavior of dilute carbon black suspensions and carbon black stabilized emulsions. Langmuir (2014) 0.75
Dilution of protein-surfactant complexes: a fluorescence study. Protein Sci (2013) 0.75
Bioengineering anembryonic human trophoblast vesicles. Reprod Sci (2010) 0.75
Architecture of Chimeric Spheroids Controls Drug Transport. Cancer Microenviron (2015) 0.75
Rapid detection and quantification of specific proteins by immunodepletion and microfluidic separation. Biotechnol J (2012) 0.75
Ligation with nucleic acid sequence-based amplification. J Mol Diagn (2012) 0.75
Designing polyHEMA substrates that mimic the viscoelastic response of soft tissue. J Biomech (2011) 0.75
Diuretic bioactivity optimization of furosemide in rats. Eur J Pharm Biopharm (2011) 0.75
Control of the timing and dosage of IGF-I delivery from encapsulated cells. J Tissue Eng Regen Med (2012) 0.75
Surfactant-induced electroosmotic flow in microfluidic capillaries. Electrophoresis (2012) 0.75
Dynamics of a capillary invasion in a closed-end capillary. Langmuir (2014) 0.75
Shear-directed assembly of graphene oxide in aqueous dispersions into ordered arrays. Langmuir (2013) 0.75
A microfluidic device for bacteria detection in aqueous samples. Environ Technol (2011) 0.75
Shear free and blotless cryo-TEM imaging: a new method for probing early evolution of nanostructures. Langmuir (2012) 0.75
Quantifying the kinetics and morphological changes of the fusion of spheroid building blocks. Biofabrication (2016) 0.75
In remembrance: Michael J. Lysaght, 1942-2009. Tissue Eng Part A (2010) 0.75
Quantifying transcription of clinically relevant immobilized DNA within a continuous flow microfluidic reactor. Langmuir (2010) 0.75
Engineering insights for multiplexed real-time nucleic acid sequence-based amplification (NASBA): implications for design of point-of-care diagnostics. Mol Diagn Ther (2013) 0.75